Trail Resistance Induces Epithelial-Mesenchymal Transition and Enhances Invasiveness by Suppressing PTEN via miR-221 in Breast Cancer

PLoS ONE - United States
doi 10.1371/journal.pone.0099067
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

miR-221&222 Regulate TRAIL Resistance and Enhance Tumorigenicity Through PTEN and TIMP3 Downregulation

Cancer Cell
Cancer ResearchOncologyCell Biology
2009English

Epithelial-Mesenchymal Transition and Drug Resistance in Breast Cancer (Review)

International Journal of Oncology
Cancer ResearchOncology
2015English

Interleukin-6 Induces Epithelial-Mesenchymal Transition in Breast Cancer Cells

Gaceta Mexicana de Oncolog�a
2019English

miR‑30a Inhibits Epithelial‑mesenchymal Transition and Metastasis in Triple‑negative Breast Cancer by Targeting ROR1

Oncology Reports
MedicineCancer ResearchOncology
2018English

Loss of TBK1 Induces Epithelial-Mesenchymal Transition in the Breast Cancer Cells by ER Downregulation

Cancer Research
Cancer ResearchOncology
2013English

miR-573 Inhibits Prostate Cancer Metastasis by Regulating Epithelial-Mesenchymal Transition

Oncotarget
Oncology
2015English

miR-15b Promotes Epithelial-Mesenchymal Transition by Inhibiting SMURF2 in Pancreatic Cancer

International Journal of Oncology
Cancer ResearchOncology
2015English

Propofol Inhibits Proliferation and Epithelial-Mesenchymal Transition of McF-7 Cells by Suppressing miR-21 Expression

Artificial Cells, Nanomedicine and Biotechnology
MedicineBiotechnologyBiomedical EngineeringPharmaceutical Science
2019English

Phosphoglucose Isomerase/Autocrine Motility Factor Mediates Epithelial-Mesenchymal Transition Regulated by miR-200 in Breast Cancer Cells

Cancer Research
Cancer ResearchOncology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy